Lewy body dementia (LBD) is a progressive brain disorder that can impair thinking, movement, behavior, mood, sleep, and automatic body functions. Symptoms often include fluctuating alertness, visual hallucinations, cognitive decline, Parkinson-like movement problems, and sleep changes; the cause is unknown, diagnosis requires several assessments, and treatment focuses on symptom control because no cure exists. LBD usually begins at age 50 or older and worsens over time. It includes two related diagnoses: dementia with Lewy bodies and Parkinson's disease dementia.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Which symptoms point to Lewy body dementia?
- What causes LBD, and who is affected?
- How do clinicians diagnose LBD?
- Which treatments can help?
- The antipsychotic safety warning
Which symptoms point to Lewy body dementia?
LBD can affect attention, reasoning, planning, and visual-spatial ability—the skills used to judge locations, distances, and relationships between objects. Memory problems may occur, but cognitive changes can extend well beyond forgetfulness. A distinctive feature is fluctuation.
A person may appear engaged and alert at one time, then confused, drowsy, or less responsive at another. Other common features include: These symptoms do not affect everyone in the same combination or sequence. The National Institute on Aging's overview of LBD symptoms emphasizes that the disorder can affect both the brain and automatic body functions.
- Detailed, realistic visual hallucinations
- Parkinson-like movement problems, known as parkinsonism
- REM sleep behavior disorder, which involves physically acting out dreams
- Changes in behavior or mood
- Constipation, fainting, or changes in blood pressure
What causes LBD, and who is affected?
Lewy bodies are abnormal deposits of a protein called alpha-synuclein. These deposits disrupt brain chemicals, but researchers do not yet know precisely why they form or why some people develop the disorder. Family history may increase risk, but LBD is not usually inherited. No genetic test can accurately predict who will develop it. LBD appears to affect slightly more men than women and generally begins at age 50 or later.
The two forms are distinguished mainly by timing. Doctors diagnose Parkinson's disease dementia when cognitive decline begins more than one year after Parkinsonian movement symptoms. When dementia appears before, alongside, or within one year of those movement symptoms, the diagnosis is dementia with Lewy bodies. Progression varies widely. The National Institute on Aging's diagnostic guide reports an average survival of five to seven years after diagnosis, with a range from two to 20 years. That average cannot predict one person's course.
How do clinicians diagnose LBD?
No single test confirms LBD during life. Clinicians instead look for a pattern across symptoms, their timing, examination findings, and test results. A diagnostic workup may include: Because alertness and behavior can fluctuate, a short written record may help describe what happens between appointments.
Note when hallucinations, confusion, unusual sleep behavior, fainting, or movement changes began and whether they vary by time of day. The National Institute on Aging explains that definitive confirmation currently requires examination of brain tissue after death. During life, diagnosis rests on the overall clinical evidence rather than one conclusive result.
- A detailed medical and symptom history
- Physical and neurological examinations
- Tests of attention, memory, reasoning, and other cognitive skills
- Laboratory tests
- A sleep study when sleep symptoms are relevant
Which treatments can help?
There is no cure or proven way to prevent LBD. Treatment is individualized because a medicine that helps one symptom can sometimes worsen another. Cholinesterase inhibitors may help cognitive or behavioral symptoms. Rivastigmine is approved for cognitive symptoms in Parkinson's disease dementia.
Levodopa may improve movement, but it does not slow the underlying disease and can worsen hallucinations or behavior. Non-drug care may include physical, occupational, and speech therapy. Counseling, caregiver support, social support, and home-safety changes can also address the practical effects of declining movement, communication, judgment, or independence. The National Institute on Aging's treatment guidance recommends matching care to the person's symptoms and needs.
The antipsychotic safety warning
People with LBD can have severe and sometimes dangerous reactions to antipsychotic medicines. Typical antipsychotics such as haloperidol generally should not be used in someone with LBD.
Medication safety requires coordination, especially when several clinicians are involved. Patients and caregivers should: Make the LBD diagnosis visible in records shared with routine, urgent, and hospital care teams so that clinicians can consider the antipsychotic risk before prescribing.
- Tell every prescriber that LBD has been diagnosed or is suspected
- Keep an up-to-date list of prescription and nonprescription medicines
- Ask an experienced clinician to review proposed treatments
- Discuss possible effects on hallucinations, behavior, movement, alertness, and blood pressure
- Avoid starting, stopping, or changing prescribed medicine without clinical guidance
